Indian stocks: Visit www.stage2stocks.com →

Alpha Tau Medical Ltd.

Stage 2 · Advancing · week 70

As of Oct 22, 2026, Alpha Tau Medical is in Stage 2, the uptrend phase, now in week 70 (since Jun 6, 2025). It closed at $12.90, 16.8% below its 52-week high and above its 200-day average, which is rising.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the t… More about the company

$12.90
-5.98% today
$1.2B · Small cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care

Is DRTS early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 19w
S4 25w
S2 72w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 1w → S3 6w → S4 19w → S1 7w → S4 25w → S1 12w → S2 12w → S3 8w → S4 3w → S1 1w → S2 72w current
Total tracked: 166 weeks across 11 stage runs.

DRTS among Biotechnology16th of 591 by relative strength

All 591 →
Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#StockStageRS1M
1GTBPStage 2 · wk 799−22.3%
2IOVAStage 2 · wk 1899+38.8%
3SLSStage 3 · wk 499−1.5%
4MRNAStage 2 · wk 1799+11.3%
5TWSTStage 2 · wk 3999−14.5%
6KODStage 2 · wk 499+172.1%
7ERASStage 3 · wk 599+0.7%
8CLYMStage 3 · wk 399−15.8%
…16DRTSStage 2 · wk 7098−11.2%
vs 52W High
-16.8%
$3.47 lo$15.50 hi
16.8% below 52W high, deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 70
1w13w26w
Week 70, extended Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
24.0%
200 DMA: $10.40 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.81x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-11.2%
3M
+3.2%
6M
+61.7%
YTD
+167.1%
1Y
+207.1%
Scan Membership
Breakout Watch
Latest: 2025-06-06
5 appearances in last 60 days. First seen: 2021-12-17.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 70 · Vol 0.81x
2026-10-21S2
Wk 70 · Vol 0.85x
2026-10-20S2
Wk 69 · Vol 1.49x
2026-10-19S2
Wk 69 · Vol 1.25x
2026-10-16S2
Wk 69 · Vol 1.43x
2026-10-15S2
Wk 69 · Vol 1.15x
2026-10-14S2
Wk 69 · Vol 0.78x
2026-10-13S2
Wk 68 · Vol 0.90x
2026-10-12S2
Wk 68 · Vol 0.52x
2026-10-09S2
Wk 68 · Vol 0.68x
2026-10-08S2
Wk 68 · Vol 1.09x
2026-10-07S2
Wk 68 · Vol 0.84x
Moving averages & range
50 DMA
$14.40
200 DMA
$10.40
52W High
$15.50
52W Low
$3.47
5D Low
$12.29
Resistance levels (recent highs)
20d High
$15.19
60d High
$15.50
120d High
$15.50
250d High
$15.50
Next resistance
+17.8%
to 20d High
ROE
-141.7%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 27.0

Alpha Tau Medical: quick answers

What stage is Alpha Tau Medical in?

As of Oct 22, 2026, Alpha Tau Medical (DRTS) is in Stage 2, the uptrend phase. It entered Stage 2 on Jun 6, 2025 and is in week 70. What the four stages mean

Is Alpha Tau Medical in an uptrend?

Yes. Alpha Tau Medical is in a Stage 2 uptrend. It trades 24.0% above its 200-day average, which is rising.

How far is Alpha Tau Medical from its 52-week high?

Alpha Tau Medical closed at $12.90 on Oct 22, 2026, 16.8% below its 52-week high of $15.50. Its 52-week low is $3.47.

How has Alpha Tau Medical performed over the past year?

As of Oct 22, 2026, Alpha Tau Medical is up 207.1% over the past year and up 167.1% so far in 2026.

Which sector and industry is Alpha Tau Medical in?

Alpha Tau Medical is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.